Cargando…
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
Pre- and post-treatment specimens from 47 patients with hormone resistant prostatic carcinoma were compared with each other regarding histological grade and immunoreactivity for p53 protein, neuron specific enolase and c-erbB-2 protein. Significantly more specimens expressed a high malignancy grade...
Autores principales: | Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968568/ https://www.ncbi.nlm.nih.gov/pubmed/7688548 |
Ejemplares similares
-
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992) -
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
por: Fosså, S. D., et al.
Publicado: (1993) -
Prostatic carcinoma: a multivariate analysis of prognostic factors.
por: Berner, A., et al.
Publicado: (1994) -
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
por: Hernes, E, et al.
Publicado: (2004) -
DNA ploidy in primary testicular cancer.
por: Fosså, S. D., et al.
Publicado: (1991)